Literature DB >> 3053987

Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors.

K Takehara1, D Ireland, D H Bishop.   

Abstract

The hepatitis B (HB) virus DNA sequences coding for the pre-core (preC) or C antigens (HBpcAg, HBcAg) have been inserted into the baculovirus plasmid transfer vector, pAcYM1, such that the HB viral sequences are under the control of the polyhedrin promoter of Autographa californica nuclear polyhedrosis virus (AcNPV). Spodoptera frugiperda cells infected with either of the derived recombinant plasmids in the presence of infectious AcNPV DNA yielded recombinant, polyhedrin-negative viruses that expressed high levels of the respective HBpcAg or HBcAg (representing approx. 5 to 10% and approx. 40% of the stained cellular proteins, respectively). The particulate 27 nm HBcAgs have been purified to homogeneity from infected cell extracts by density gradient centrifugation. Dual expression transfer vectors containing the HBcAg gene sequences and the coding sequences of the HB viral S antigen (HBsAg), each gene under the control of its own copy of the polyhedrin promoter, have also been constructed and used to derive recombinant viruses. The recombinant with the HB C and S genes expressed high levels of the HBcAg (approx. 40% of the cellular proteins) and low levels of the HBsAg (approx. 2% of the stained cellular proteins). Dual expression, occluded, recombinant baculoviruses that make HBsAg, as well as the AcNPV polyhedrin protein, have been prepared that are highly infectious for Trichoplusia ni caterpillars, allowing reproducible preparation of the antigen in larvae. Using radioimmunoassays (RIAs) and ELISAs, the recombinant HBcAg (RIA) and HBsAg (ELISA) have been used to identify human antibodies to HB virus with results that compare favourably with the data obtained with non-recombinant antigens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053987     DOI: 10.1099/0022-1317-69-11-2763

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins.

Authors:  M Sabara; M Parker; P Aha; C Cosco; E Gibbons; S Parsons; L A Babiuk
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

Authors:  H Ghiasi; A B Nesburn; R Kaiwar; S L Wechsler
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Concomitant cellular expression of heat shock regulated genes of hepatitis B virus surface antigen and of human growth hormone by a NIH-3T3 cell line.

Authors:  P L'Hote; S Alouani; J B Marq; F Montandon; M Chessebeuf-Padieu; M Dreano
Journal:  Cell Biol Toxicol       Date:  1993 Oct-Dec       Impact factor: 6.691

4.  Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

Authors:  T J French; J J Marshall; P Roy
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV.

Authors:  T J French; P Roy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation.

Authors:  B Beames; R E Lanford
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.

Authors:  W W Ye; B B Mason; M Chengalvala; S M Cheng; G Zandle; M D Lubeck; S G Lee; S Mizutani; A R Davis; P P Hung
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Recombinant vaccine for canine parvovirus in dogs.

Authors:  J A López de Turiso; E Cortés; C Martínez; R Ruiz de Ybáñez; I Simarro; C Vela; I Casal
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens.

Authors:  Y W Hu; P Birch; E Balaskas; A Zeibdawi; V Scalia; S A Thériault-Valin; P Gill; M T Aye
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.